-
1
-
-
0025074907
-
In vitro selection of RNA molecules that bind specific ligands
-
Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
-
(1990)
Nature
, vol.346
, pp. 818-822
-
-
Ellington, A.D.1
Szostak, J.W.2
-
2
-
-
0025194307
-
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase
-
Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
-
(1990)
Science
, vol.249
, pp. 505-510
-
-
Tuerk, C.1
Gold, L.2
-
3
-
-
0027172294
-
The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer
-
Padmanabhan K., Padmanabhan K.P., Ferrara J.D., Sadler J.E., Tulinsky A. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J. Biol. Chem. 1993, 268:17651-17654.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 17651-17654
-
-
Padmanabhan, K.1
Padmanabhan, K.P.2
Ferrara, J.D.3
Sadler, J.E.4
Tulinsky, A.5
-
4
-
-
57049152364
-
Crystal structure of an RNA aptamer bound to thrombin
-
Long S.B., Long M.B., White R.R., Sullenger B.A. Crystal structure of an RNA aptamer bound to thrombin. RNA 2008, 14:2504-2512.
-
(2008)
RNA
, vol.14
, pp. 2504-2512
-
-
Long, S.B.1
Long, M.B.2
White, R.R.3
Sullenger, B.A.4
-
5
-
-
0028332939
-
Molecular mapping of the heparin-binding exosite of thrombin
-
Sheehan J.P., Sadler J.E. Molecular mapping of the heparin-binding exosite of thrombin. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5518-5522.
-
(1994)
Proc. Natl. Acad. Sci. U. S. A.
, vol.91
, pp. 5518-5522
-
-
Sheehan, J.P.1
Sadler, J.E.2
-
6
-
-
0027050807
-
The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships
-
Bode W., Turk D., Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1992, 1:426-471.
-
(1992)
Protein Sci.
, vol.1
, pp. 426-471
-
-
Bode, W.1
Turk, D.2
Karshikov, A.3
-
11
-
-
0037015078
-
Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription
-
Siddiqui-Jain A., Grand C.L., Bearss D.J., Hurley L.H. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11593-11598.
-
(2002)
Proc. Natl. Acad. Sci. U. S. A.
, vol.99
, pp. 11593-11598
-
-
Siddiqui-Jain, A.1
Grand, C.L.2
Bearss, D.J.3
Hurley, L.H.4
-
12
-
-
14144254793
-
An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase
-
Phan A.T., Kuryavyi V., Ma J.B., Faure A., Andreola M.L., Patel D.J. An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:634-639.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 634-639
-
-
Phan, A.T.1
Kuryavyi, V.2
Ma, J.B.3
Faure, A.4
Andreola, M.L.5
Patel, D.J.6
-
13
-
-
35948945681
-
AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin
-
Teng Y., Girvan A.C., Casson L.K., Pierce W.M., Qian M., Thomas S.D., Bates P.J. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res. 2007, 67:10491-10500.
-
(2007)
Cancer Res.
, vol.67
, pp. 10491-10500
-
-
Teng, Y.1
Girvan, A.C.2
Casson, L.K.3
Pierce, W.M.4
Qian, M.5
Thomas, S.D.6
Bates, P.J.7
-
14
-
-
66249097058
-
Functional nucleic acid sensors
-
Liu J., Cao Z., Lu Y. Functional nucleic acid sensors. Chem. Rev. 2009, 109:1948-1998.
-
(2009)
Chem. Rev.
, vol.109
, pp. 1948-1998
-
-
Liu, J.1
Cao, Z.2
Lu, Y.3
-
15
-
-
77951731728
-
Deoxyribozymes: selection design and serendipity in the development of DNA catalysts
-
Silverman S.K. Deoxyribozymes: selection design and serendipity in the development of DNA catalysts. Acc. Chem. Res. 2009, 42:1521-1531.
-
(2009)
Acc. Chem. Res.
, vol.42
, pp. 1521-1531
-
-
Silverman, S.K.1
-
16
-
-
0033168844
-
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature
-
Chang S.S., Reuter V.E., Heston W.D., Bander N.H., Grauer L.S., Gaudin P.B. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res. 1999, 59:3192-3198.
-
(1999)
Cancer Res.
, vol.59
, pp. 3192-3198
-
-
Chang, S.S.1
Reuter, V.E.2
Heston, W.D.3
Bander, N.H.4
Grauer, L.S.5
Gaudin, P.B.6
-
17
-
-
0346333234
-
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer
-
Ross J.S., Sheehan C.E., Fisher H.A., Kaufman R.P., Kaur P., Gray K., Webb I., Gray G.S., Mosher R., Kallakury B.V. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin. Cancer Res. 2003, 9:6357-6362.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 6357-6362
-
-
Ross, J.S.1
Sheehan, C.E.2
Fisher, H.A.3
Kaufman, R.P.4
Kaur, P.5
Gray, K.6
Webb, I.7
Gray, G.S.8
Mosher, R.9
Kallakury, B.V.10
-
18
-
-
0037099536
-
Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen
-
Lupold S.E., Hicke B.J., Lin Y., Coffey D.S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 2002, 62:4029-4033.
-
(2002)
Cancer Res.
, vol.62
, pp. 4029-4033
-
-
Lupold, S.E.1
Hicke, B.J.2
Lin, Y.3
Coffey, D.S.4
-
19
-
-
0032530135
-
Constitutive and antibody-induced internalization of prostate-specific membrane antigen
-
Liu H., Rajasekaran A.K., Moy P., Xia Y., Kim S., Navarro V., Rahmati R., Bander N.H. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res. 1998, 58:4055-4060.
-
(1998)
Cancer Res.
, vol.58
, pp. 4055-4060
-
-
Liu, H.1
Rajasekaran, A.K.2
Moy, P.3
Xia, Y.4
Kim, S.5
Navarro, V.6
Rahmati, R.7
Bander, N.H.8
-
20
-
-
0028933376
-
Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression
-
Su S.L., Huang I.P., Fair W.R., Powell C.T., Heston W.D. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res. 1995, 55:1441-1443.
-
(1995)
Cancer Res.
, vol.55
, pp. 1441-1443
-
-
Su, S.L.1
Huang, I.P.2
Fair, W.R.3
Powell, C.T.4
Heston, W.D.5
-
21
-
-
33747031960
-
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
-
McNamara J.O., Andrechek E.R., Wang Y., Viles K.D., Rempel R.E., Gilboa E., Sullenger B.A., Giangrande P.H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 2006, 24:1005-1015.
-
(2006)
Nat. Biotechnol.
, vol.24
, pp. 1005-1015
-
-
McNamara, J.O.1
Andrechek, E.R.2
Wang, Y.3
Viles, K.D.4
Rempel, R.E.5
Gilboa, E.6
Sullenger, B.A.7
Giangrande, P.H.8
-
22
-
-
0028909393
-
Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules
-
Freeman S.D., Kelm S., Barber E.K., Crocker P.R. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 1995, 85:2005-2012.
-
(1995)
Blood
, vol.85
, pp. 2005-2012
-
-
Freeman, S.D.1
Kelm, S.2
Barber, E.K.3
Crocker, P.R.4
-
23
-
-
0020620217
-
Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies
-
Andrews R.G., Torok-Storb B., Bernstein I.D. Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies. Blood 1983, 62:124-132.
-
(1983)
Blood
, vol.62
, pp. 124-132
-
-
Andrews, R.G.1
Torok-Storb, B.2
Bernstein, I.D.3
-
24
-
-
0022806814
-
The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors
-
Andrews R.G., Takahashi M., Segal G.M., Powell J.S., Bernstein I.D., Singer J.W. The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood 1986, 68:1030-1035.
-
(1986)
Blood
, vol.68
, pp. 1030-1035
-
-
Andrews, R.G.1
Takahashi, M.2
Segal, G.M.3
Powell, J.S.4
Bernstein, I.D.5
Singer, J.W.6
-
25
-
-
0021222051
-
A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells
-
Griffin J.D., Linch D., Sabbath K., Larcom P., Schlossman S.F. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk. Res. 1984, 8:521-534.
-
(1984)
Leuk. Res.
, vol.8
, pp. 521-534
-
-
Griffin, J.D.1
Linch, D.2
Sabbath, K.3
Larcom, P.4
Schlossman, S.F.5
-
26
-
-
0022626628
-
Expression of normal myeloid-associated antigens by acute leukemia cells
-
Dinndorf P.A., Andrews R.G., Benjamin D., Ridgway D., Wolff L., Bernstein I.D. Expression of normal myeloid-associated antigens by acute leukemia cells. Blood 1986, 67:1048-1053.
-
(1986)
Blood
, vol.67
, pp. 1048-1053
-
-
Dinndorf, P.A.1
Andrews, R.G.2
Benjamin, D.3
Ridgway, D.4
Wolff, L.5
Bernstein, I.D.6
-
27
-
-
0024401832
-
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia
-
Scheinberg D.A., Tanimoto M., McKenzie S., Strife A., Old L.J., Clarkson B.D. Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia. Leukemia 1989, 3:440-445.
-
(1989)
Leukemia
, vol.3
, pp. 440-445
-
-
Scheinberg, D.A.1
Tanimoto, M.2
McKenzie, S.3
Strife, A.4
Old, L.J.5
Clarkson, B.D.6
-
28
-
-
0026560106
-
Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis
-
Terstappen L.W., Safford M., Konemann S., Loken M.R., Zurlutter K., Buchner T., Hiddemann W., Wormann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1992, 6:70-80.
-
(1992)
Leukemia
, vol.6
, pp. 70-80
-
-
Terstappen, L.W.1
Safford, M.2
Konemann, S.3
Loken, M.R.4
Zurlutter, K.5
Buchner, T.6
Hiddemann, W.7
Wormann, B.8
-
29
-
-
0032147024
-
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies
-
Putti M.C., Rondelli R., Cocito M.G., Arico M., Sainati L., Conter V., Guglielmi C., Cantu-Rajnoldi A., Consolini R., Pession A., Zanesco L., Masera G., Biondi A., Basso G. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood 1998, 92:795-801.
-
(1998)
Blood
, vol.92
, pp. 795-801
-
-
Putti, M.C.1
Rondelli, R.2
Cocito, M.G.3
Arico, M.4
Sainati, L.5
Conter, V.6
Guglielmi, C.7
Cantu-Rajnoldi, A.8
Consolini, R.9
Pession, A.10
Zanesco, L.11
Masera, G.12
Biondi, A.13
Basso, G.14
-
30
-
-
0034050268
-
Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate
-
Bernstein I.D. Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate. Leukemia 2000, 14:474-475.
-
(2000)
Leukemia
, vol.14
, pp. 474-475
-
-
Bernstein, I.D.1
-
31
-
-
0036007598
-
An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker
-
Hamann P.R., Hinman L.M., Beyer C.F., Lindh D., Upeslacis J., Flowers D.A., Bernstein I. An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Bioconjug. Chem. 2002, 13:40-46.
-
(2002)
Bioconjug. Chem.
, vol.13
, pp. 40-46
-
-
Hamann, P.R.1
Hinman, L.M.2
Beyer, C.F.3
Lindh, D.4
Upeslacis, J.5
Flowers, D.A.6
Bernstein, I.7
-
32
-
-
0035874504
-
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
-
van Der Velden V.H., te Marvelde J.G., Hoogeveen P.G., Bernstein I.D., Houtsmuller A.B., Berger M.S., van Dongen J.J. Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells. Blood 2001, 97:3197-3204.
-
(2001)
Blood
, vol.97
, pp. 3197-3204
-
-
van Der Velden, V.H.1
te Marvelde, J.G.2
Hoogeveen, P.G.3
Bernstein, I.D.4
Houtsmuller, A.B.5
Berger, M.S.6
van Dongen, J.J.7
-
33
-
-
12844257365
-
Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity
-
Walter R.B., Raden B.W., Kamikura D.M., Cooper J.A., Bernstein I.D. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity. Blood 2005, 105:1295-1302.
-
(2005)
Blood
, vol.105
, pp. 1295-1302
-
-
Walter, R.B.1
Raden, B.W.2
Kamikura, D.M.3
Cooper, J.A.4
Bernstein, I.D.5
-
34
-
-
33644860896
-
The role of gemtuzumab ozogamicin in acute leukaemia therapy
-
Tsimberidou A.M., Giles F.J., Estey E., O'Brien S., Keating M.J., Kantarjian H.M. The role of gemtuzumab ozogamicin in acute leukaemia therapy. Br. J. Haematol. 2006, 132:398-409.
-
(2006)
Br. J. Haematol.
, vol.132
, pp. 398-409
-
-
Tsimberidou, A.M.1
Giles, F.J.2
Estey, E.3
O'Brien, S.4
Keating, M.J.5
Kantarjian, H.M.6
-
35
-
-
2342572260
-
High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients
-
van der Velden V.H., Boeckx N., Jedema I., te Marvelde J.G., Hoogeveen P.G., Boogaerts M., van Dongen J.J. High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients. Leukemia 2004, 18:983-988.
-
(2004)
Leukemia
, vol.18
, pp. 983-988
-
-
van der Velden, V.H.1
Boeckx, N.2
Jedema, I.3
te Marvelde, J.G.4
Hoogeveen, P.G.5
Boogaerts, M.6
van Dongen, J.J.7
-
36
-
-
55949115599
-
Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease
-
Chevallier P., Robillard N., Ayari S., Guillaume T., Delaunay J., Mechinaud F., Avet-Loiseau H., Mohty M., Harousseau J.L., Garand R. Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease. Br. J. Haematol. 2008, 143:744-746.
-
(2008)
Br. J. Haematol.
, vol.143
, pp. 744-746
-
-
Chevallier, P.1
Robillard, N.2
Ayari, S.3
Guillaume, T.4
Delaunay, J.5
Mechinaud, F.6
Avet-Loiseau, H.7
Mohty, M.8
Harousseau, J.L.9
Garand, R.10
-
37
-
-
33745546232
-
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells
-
Chen P., Wang J., Hope K., Jin L., Dick J., Cameron R., Brandwein J., Minden M., Reilly R.M. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. J. Nucl. Med. 2006, 47:827-836.
-
(2006)
J. Nucl. Med.
, vol.47
, pp. 827-836
-
-
Chen, P.1
Wang, J.2
Hope, K.3
Jin, L.4
Dick, J.5
Cameron, R.6
Brandwein, J.7
Minden, M.8
Reilly, R.M.9
-
38
-
-
76549177140
-
Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques
-
Gold P., Freedman S.O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med. 1965, 121:439-462.
-
(1965)
J. Exp. Med.
, vol.121
, pp. 439-462
-
-
Gold, P.1
Freedman, S.O.2
-
39
-
-
0033057177
-
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
-
Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 1999, 9:67-81.
-
(1999)
Semin. Cancer Biol.
, vol.9
, pp. 67-81
-
-
Hammarstrom, S.1
-
40
-
-
0024517116
-
Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue
-
Boucher D., Cournoyer D., Stanners C.P., Fuks A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res. 1989, 49:847-852.
-
(1989)
Cancer Res.
, vol.49
, pp. 847-852
-
-
Boucher, D.1
Cournoyer, D.2
Stanners, C.P.3
Fuks, A.4
-
41
-
-
24744451447
-
Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer
-
Goldstein M.J., Mitchell E.P. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 2005, 23:338-351.
-
(2005)
Cancer Invest.
, vol.23
, pp. 338-351
-
-
Goldstein, M.J.1
Mitchell, E.P.2
-
42
-
-
0027979880
-
Internalization of an intact doxorubicin immunoconjugate
-
Shih L.B., Goldenberg D.M., Xuan H., Lu H.W., Mattes M.J., Hall T.C. Internalization of an intact doxorubicin immunoconjugate. Cancer Immunol. Immunother. 1994, 38:92-98.
-
(1994)
Cancer Immunol. Immunother.
, vol.38
, pp. 92-98
-
-
Shih, L.B.1
Goldenberg, D.M.2
Xuan, H.3
Lu, H.W.4
Mattes, M.J.5
Hall, T.C.6
-
43
-
-
0029966481
-
Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody
-
Ford C.H., Tsaltas G.C., Osborne P.A., Addetia K. Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody. Cytometry 1996, 23:228-240.
-
(1996)
Cytometry
, vol.23
, pp. 228-240
-
-
Ford, C.H.1
Tsaltas, G.C.2
Osborne, P.A.3
Addetia, K.4
-
44
-
-
0032930201
-
Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs
-
Stein R., Juweid M., Mattes M.J., Goldenberg D.M. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs. Cancer Biother. Radiopharm. 1999, 14:37-47.
-
(1999)
Cancer Biother. Radiopharm.
, vol.14
, pp. 37-47
-
-
Stein, R.1
Juweid, M.2
Mattes, M.J.3
Goldenberg, D.M.4
-
45
-
-
52549121490
-
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
-
Schmidt M.M., Thurber G.M., Wittrup K.D. Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability. Cancer Immunol. Immunother. 2008, 57:1879-1890.
-
(2008)
Cancer Immunol. Immunother.
, vol.57
, pp. 1879-1890
-
-
Schmidt, M.M.1
Thurber, G.M.2
Wittrup, K.D.3
-
46
-
-
0036255688
-
Targeted therapy of cancer with radiolabeled antibodies
-
Goldenberg D.M. Targeted therapy of cancer with radiolabeled antibodies. J. Nucl. Med. 2002, 43:693-713.
-
(2002)
J. Nucl. Med.
, vol.43
, pp. 693-713
-
-
Goldenberg, D.M.1
-
47
-
-
0037083619
-
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer
-
Behr T.M., Liersch T., Greiner-Bechert L., Griesinger F., Behe M., Markus P.M., Gratz S., Angerstein C., Brittinger G., Becker H., Goldenberg D.M., Becker W. Radioimmunotherapy of small-volume disease of metastatic colorectal cancer. Cancer 2002, 94:1373-1381.
-
(2002)
Cancer
, vol.94
, pp. 1373-1381
-
-
Behr, T.M.1
Liersch, T.2
Greiner-Bechert, L.3
Griesinger, F.4
Behe, M.5
Markus, P.M.6
Gratz, S.7
Angerstein, C.8
Brittinger, G.9
Becker, H.10
Goldenberg, D.M.11
Becker, W.12
-
48
-
-
0035874887
-
High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules
-
Adams G.P., Schier R., McCall A.M., Simmons H.H., Horak E.M., Alpaugh R.K., Marks J.D., Weiner L.M. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 2001, 61:4750-4755.
-
(2001)
Cancer Res.
, vol.61
, pp. 4750-4755
-
-
Adams, G.P.1
Schier, R.2
McCall, A.M.3
Simmons, H.H.4
Horak, E.M.5
Alpaugh, R.K.6
Marks, J.D.7
Weiner, L.M.8
-
49
-
-
0037444270
-
Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention
-
Graff C.P., Wittrup K.D. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. Cancer Res. 2003, 63:1288-1296.
-
(2003)
Cancer Res.
, vol.63
, pp. 1288-1296
-
-
Graff, C.P.1
Wittrup, K.D.2
-
50
-
-
0025766226
-
Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line
-
Robbins P.F., Kantor J.A., Salgaller M., Hand P.H., Fernsten P.D., Schlom J. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res. 1991, 51:3657-3662.
-
(1991)
Cancer Res.
, vol.51
, pp. 3657-3662
-
-
Robbins, P.F.1
Kantor, J.A.2
Salgaller, M.3
Hand, P.H.4
Fernsten, P.D.5
Schlom, J.6
-
51
-
-
0028957721
-
Prognostic significance of MUC1 epithelial mucin expression in breast cancer
-
McGuckin M.A., Walsh M.D., Hohn B.G., Ward B.G., Wright R.G. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum. Pathol. 1995, 26:432-439.
-
(1995)
Hum. Pathol.
, vol.26
, pp. 432-439
-
-
McGuckin, M.A.1
Walsh, M.D.2
Hohn, B.G.3
Ward, B.G.4
Wright, R.G.5
-
52
-
-
0029589586
-
Delayed mammary tumor progression in Muc-1 null mice
-
Spicer A.P., Rowse G.J., Lidner T.K., Gendler S.J. Delayed mammary tumor progression in Muc-1 null mice. J. Biol. Chem. 1995, 270:30093-30101.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 30093-30101
-
-
Spicer, A.P.1
Rowse, G.J.2
Lidner, T.K.3
Gendler, S.J.4
-
53
-
-
0032852259
-
MUC1 and cancer
-
Taylor-Papadimitriou J., Burchell J., Miles D.W., Dalziel M. MUC1 and cancer. Biochim. Biophys. Acta 1999, 1455:301-313.
-
(1999)
Biochim. Biophys. Acta
, vol.1455
, pp. 301-313
-
-
Taylor-Papadimitriou, J.1
Burchell, J.2
Miles, D.W.3
Dalziel, M.4
-
54
-
-
0343570538
-
MUC1: the polymorphic appearance of a human mucin
-
Hanisch F.G., Muller S. MUC1: the polymorphic appearance of a human mucin. Glycobiology 2000, 10:439-449.
-
(2000)
Glycobiology
, vol.10
, pp. 439-449
-
-
Hanisch, F.G.1
Muller, S.2
-
55
-
-
0023741252
-
A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats
-
Gendler S., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 1988, 263:12820-12823.
-
(1988)
J. Biol. Chem.
, vol.263
, pp. 12820-12823
-
-
Gendler, S.1
Taylor-Papadimitriou, J.2
Duhig, T.3
Rothbard, J.4
Burchell, J.5
-
56
-
-
0029966497
-
MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation
-
Hanisch F.G., Stadie T.R., Deutzmann F., Peter-Katalinic J. MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. Eur. J. Biochem. 1996, 236:318-327.
-
(1996)
Eur. J. Biochem.
, vol.236
, pp. 318-327
-
-
Hanisch, F.G.1
Stadie, T.R.2
Deutzmann, F.3
Peter-Katalinic, J.4
-
57
-
-
0030466993
-
Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells
-
Lloyd K.O., Burchell J., Kudryashov V., Yin B.W., Taylor-Papadimitriou J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 1996, 271:33325-33334.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 33325-33334
-
-
Lloyd, K.O.1
Burchell, J.2
Kudryashov, V.3
Yin, B.W.4
Taylor-Papadimitriou, J.5
-
58
-
-
0027383762
-
The epithelial sialomucin, episialin, is sialylated during recycling
-
Litvinov S.V., Hilkens J. The epithelial sialomucin, episialin, is sialylated during recycling. J. Biol. Chem. 1993, 268:21364-21371.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 21364-21371
-
-
Litvinov, S.V.1
Hilkens, J.2
-
59
-
-
0026716608
-
Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis
-
Ceriani R.L., Chan C.M., Baratta F.S., Ozzello L., DeRosa C.M., Habif D.V. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis. Int. J. Cancer 1992, 51:343-354.
-
(1992)
Int. J. Cancer
, vol.51
, pp. 343-354
-
-
Ceriani, R.L.1
Chan, C.M.2
Baratta, F.S.3
Ozzello, L.4
DeRosa, C.M.5
Habif, D.V.6
-
60
-
-
0034063270
-
Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state
-
Altschuler Y., Kinlough C.L., Poland P.A., Bruns J.B., Apodaca G., Weisz O.A., Hughey R.P. Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. Mol. Biol. Cell 2000, 11:819-831.
-
(2000)
Mol. Biol. Cell
, vol.11
, pp. 819-831
-
-
Altschuler, Y.1
Kinlough, C.L.2
Poland, P.A.3
Bruns, J.B.4
Apodaca, G.5
Weisz, O.A.6
Hughey, R.P.7
-
61
-
-
0036098248
-
A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized
-
Henderikx P., Coolen-van Neer N., Jacobs A., van der Linden E., Arends J.W., Mullberg J., Hoogenboom H.R. A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized. Am. J. Pathol. 2002, 160:1597-1608.
-
(2002)
Am. J. Pathol.
, vol.160
, pp. 1597-1608
-
-
Henderikx, P.1
Coolen-van Neer, N.2
Jacobs, A.3
van der Linden, E.4
Arends, J.W.5
Mullberg, J.6
Hoogenboom, H.R.7
-
62
-
-
63349112005
-
Phototoxic aptamers selectively enter and kill epithelial cancer cells
-
Ferreira C.S., Cheung M.C., Missailidis S., Bisland S., Gariepy J. Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Res. 2009, 37:866-876.
-
(2009)
Nucleic Acids Res.
, vol.37
, pp. 866-876
-
-
Ferreira, C.S.1
Cheung, M.C.2
Missailidis, S.3
Bisland, S.4
Gariepy, J.5
-
63
-
-
65549102827
-
Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells
-
Huang Y.F., Shangguan D., Liu H., Phillips J.A., Zhang X., Chen Y., Tan W. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem 2009, 10:862-868.
-
(2009)
Chembiochem
, vol.10
, pp. 862-868
-
-
Huang, Y.F.1
Shangguan, D.2
Liu, H.3
Phillips, J.A.4
Zhang, X.5
Chen, Y.6
Tan, W.7
-
64
-
-
33845723241
-
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform
-
Bagalkot V., Farokhzad O.C., Langer R., Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew. Chem. Int. Ed. Engl. 2006, 45:8149-8152.
-
(2006)
Angew. Chem. Int. Ed. Engl.
, vol.45
, pp. 8149-8152
-
-
Bagalkot, V.1
Farokhzad, O.C.2
Langer, R.3
Jon, S.4
-
65
-
-
0027134326
-
(6-Maleimidocaproyl)hydrazone of doxorubicin-a new derivative for the preparation of immunoconjugates of doxorubicin
-
Willner D., Trail P.A., Hofstead S.J., King H.D., Lasch S.J., Braslawsky G.R., Greenfield R.S., Kaneko T., Firestone R.A. (6-Maleimidocaproyl)hydrazone of doxorubicin-a new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjug. Chem. 1993, 4:521-527.
-
(1993)
Bioconjug. Chem.
, vol.4
, pp. 521-527
-
-
Willner, D.1
Trail, P.A.2
Hofstead, S.J.3
King, H.D.4
Lasch, S.J.5
Braslawsky, G.R.6
Greenfield, R.S.7
Kaneko, T.8
Firestone, R.A.9
-
66
-
-
0024449567
-
Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis
-
Goldmacher V.S., Scott C.F., Lambert J.M., McIntyre G.D., Blattler W.A., Collnhson A.R., Stewart J.K., Chong L.D., Cook S., Slayter H.S., et al. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis. J. Cell. Physiol. 1989, 141:222-234.
-
(1989)
J. Cell. Physiol.
, vol.141
, pp. 222-234
-
-
Goldmacher, V.S.1
Scott, C.F.2
Lambert, J.M.3
McIntyre, G.D.4
Blattler, W.A.5
Collnhson, A.R.6
Stewart, J.K.7
Chong, L.D.8
Cook, S.9
Slayter, H.S.10
-
67
-
-
33745714275
-
Aptamer:toxin conjugates that specifically target prostate tumor cells
-
Chu T.C., Marks J.W., Lavery L.A., Faulkner S., Rosenblum M.G., Ellington A.D., Levy M. Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res. 2006, 66:5989-5992.
-
(2006)
Cancer Res.
, vol.66
, pp. 5989-5992
-
-
Chu, T.C.1
Marks, J.W.2
Lavery, L.A.3
Faulkner, S.4
Rosenblum, M.G.5
Ellington, A.D.6
Levy, M.7
-
68
-
-
33745108827
-
Tumor targeting by an aptamer
-
Hicke B.J., Stephens A.W., Gould T., Chang Y.F., Lynott C.K., Heil J., Borkowski S., Hilger C.S., Cook G., Warren S., Schmidt P.G. Tumor targeting by an aptamer. J. Nucl. Med. 2006, 47:668-678.
-
(2006)
J. Nucl. Med.
, vol.47
, pp. 668-678
-
-
Hicke, B.J.1
Stephens, A.W.2
Gould, T.3
Chang, Y.F.4
Lynott, C.K.5
Heil, J.6
Borkowski, S.7
Hilger, C.S.8
Cook, G.9
Warren, S.10
Schmidt, P.G.11
-
69
-
-
0035966106
-
Tenascin-C aptamers are generated using tumor cells and purified protein
-
Hicke B.J., Marion C., Chang Y.F., Gould T., Lynott C.K., Parma D., Schmidt P.G., Warren S. Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 2001, 276:48644-48654.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 48644-48654
-
-
Hicke, B.J.1
Marion, C.2
Chang, Y.F.3
Gould, T.4
Lynott, C.K.5
Parma, D.6
Schmidt, P.G.7
Warren, S.8
-
70
-
-
38849194768
-
Cancer cell targeting using multiple aptamers conjugated on nanorods
-
Huang Y.F., Chang H.T., Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal. Chem. 2008, 80:567-572.
-
(2008)
Anal. Chem.
, vol.80
, pp. 567-572
-
-
Huang, Y.F.1
Chang, H.T.2
Tan, W.3
-
71
-
-
33645238918
-
Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates
-
Chu T.C., Shieh F., Lavery L.A., Levy M., Richards-Kortum R., Korgel B.A., Ellington A.D. Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates. Biosens. Bioelectron. 2006, 21:1859-1866.
-
(2006)
Biosens. Bioelectron.
, vol.21
, pp. 1859-1866
-
-
Chu, T.C.1
Shieh, F.2
Lavery, L.A.3
Levy, M.4
Richards-Kortum, R.5
Korgel, B.A.6
Ellington, A.D.7
-
72
-
-
7444223607
-
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells
-
Farokhzad O.C., Jon S., Khademhosseini A., Tran T.N., Lavan D.A., Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 2004, 64:7668-7672.
-
(2004)
Cancer Res.
, vol.64
, pp. 7668-7672
-
-
Farokhzad, O.C.1
Jon, S.2
Khademhosseini, A.3
Tran, T.N.4
Lavan, D.A.5
Langer, R.6
-
73
-
-
33646582037
-
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
-
Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6315-6320.
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.103
, pp. 6315-6320
-
-
Farokhzad, O.C.1
Cheng, J.2
Teply, B.A.3
Sherifi, I.4
Jon, S.5
Kantoff, P.W.6
Richie, J.P.7
Langer, R.8
-
74
-
-
42349106952
-
Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates
-
Zhang L., Radovic-Moreno A.F., Alexis F., Gu F.X., Basto P.A., Bagalkot V., Jon S., Langer R.S., Farokhzad O.C. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. Chem. Med. Chem. 2007, 2:1268-1271.
-
(2007)
Chem. Med. Chem.
, vol.2
, pp. 1268-1271
-
-
Zhang, L.1
Radovic-Moreno, A.F.2
Alexis, F.3
Gu, F.X.4
Basto, P.A.5
Bagalkot, V.6
Jon, S.7
Langer, R.S.8
Farokhzad, O.C.9
-
75
-
-
56249097260
-
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
-
Dhar S., Gu F.X., Langer R., Farokhzad O.C., Lippard S.J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17356-17361.
-
(2008)
Proc. Natl. Acad. Sci. U. S. A.
, vol.105
, pp. 17356-17361
-
-
Dhar, S.1
Gu, F.X.2
Langer, R.3
Farokhzad, O.C.4
Lippard, S.J.5
-
76
-
-
36248973801
-
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer
-
Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P.W., Langer R., Farokhzad O.C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett. 2007, 7:3065-3070.
-
(2007)
Nano Lett.
, vol.7
, pp. 3065-3070
-
-
Bagalkot, V.1
Zhang, L.2
Levy-Nissenbaum, E.3
Jon, S.4
Kantoff, P.W.5
Langer, R.6
Farokhzad, O.C.7
-
77
-
-
0034734990
-
Virosomes: evolution of the liposome as a targeted drug delivery system
-
Kaneda Y. Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev. 2000, 43:197-205.
-
(2000)
Adv. Drug Deliv. Rev.
, vol.43
, pp. 197-205
-
-
Kaneda, Y.1
-
78
-
-
33748581303
-
GMP production of liposomes-a new industrial approach
-
Wagner A., Platzgummer M., Kreismayr G., Quendler H., Stiegler G., Ferko B., Vecera G., Vorauer-Uhl K., Katinger H. GMP production of liposomes-a new industrial approach. J. Liposome Res. 2006, 16:311-319.
-
(2006)
J. Liposome Res.
, vol.16
, pp. 311-319
-
-
Wagner, A.1
Platzgummer, M.2
Kreismayr, G.3
Quendler, H.4
Stiegler, G.5
Ferko, B.6
Vecera, G.7
Vorauer-Uhl, K.8
Katinger, H.9
-
79
-
-
0032170107
-
Liposome-anchored vascular endothelial growth factor aptamers
-
Willis M.C., Collins B.D., Zhang T., Green L.S., Sebesta D.P., Bell C., Kellogg E., Gill S.C., Magallanez A., Knauer S., Bendele R.A., Gill P.S., Janjic N. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug. Chem. 1998, 9:573-582.
-
(1998)
Bioconjug. Chem.
, vol.9
, pp. 573-582
-
-
Willis, M.C.1
Collins, B.D.2
Zhang, T.3
Green, L.S.4
Sebesta, D.P.5
Bell, C.6
Kellogg, E.7
Gill, S.C.8
Magallanez, A.9
Knauer, S.10
Bendele, R.A.11
Gill, P.S.12
Janjic, N.13
-
80
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
-
Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46:6387-6392.
-
(1986)
Cancer Res.
, vol.46
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
81
-
-
0037731636
-
Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells
-
Mamot C., Drummond D.C., Greiser U., Hong K., Kirpotin D.B., Marks J.D., Park J.W. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 2003, 63:3154-3161.
-
(2003)
Cancer Res.
, vol.63
, pp. 3154-3161
-
-
Mamot, C.1
Drummond, D.C.2
Greiser, U.3
Hong, K.4
Kirpotin, D.B.5
Marks, J.D.6
Park, J.W.7
-
82
-
-
37449033076
-
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes
-
Woo J., Chiu G.N., Karlsson G., Wasan E., Ickenstein L., Edwards K., Bally M.B. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes. Int. J. Pharm. 2008, 349:38-46.
-
(2008)
Int. J. Pharm.
, vol.349
, pp. 38-46
-
-
Woo, J.1
Chiu, G.N.2
Karlsson, G.3
Wasan, E.4
Ickenstein, L.5
Edwards, K.6
Bally, M.B.7
-
83
-
-
0026575221
-
Selection of single-stranded DNA molecules that bind and inhibit human thrombin
-
Bock L.C., Griffin L.C., Latham J.A., Vermaas E.H., Toole J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992, 355:564-566.
-
(1992)
Nature
, vol.355
, pp. 564-566
-
-
Bock, L.C.1
Griffin, L.C.2
Latham, J.A.3
Vermaas, E.H.4
Toole, J.J.5
-
84
-
-
34249320140
-
Beyond the platelet count: heparin antibodies as independent risk predictors
-
Stribling W.K., Slaughter T.F., Houle T.T., Sane D.C. Beyond the platelet count: heparin antibodies as independent risk predictors. Am. Heart J. 2007, 153:900-906.
-
(2007)
Am. Heart J.
, vol.153
, pp. 900-906
-
-
Stribling, W.K.1
Slaughter, T.F.2
Houle, T.T.3
Sane, D.C.4
-
85
-
-
0029165745
-
High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus
-
Schneider D.J., Feigon J., Hostomsky Z., Gold L. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 1995, 34:9599-9610.
-
(1995)
Biochemistry
, vol.34
, pp. 9599-9610
-
-
Schneider, D.J.1
Feigon, J.2
Hostomsky, Z.3
Gold, L.4
-
87
-
-
66249129385
-
Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells
-
Zhou J., Swiderski P., Li H., Zhang J., Neff C.P., Akkina R., Rossi J.J. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res. 2009, 37:3094-3109.
-
(2009)
Nucleic Acids Res.
, vol.37
, pp. 3094-3109
-
-
Zhou, J.1
Swiderski, P.2
Li, H.3
Zhang, J.4
Neff, C.P.5
Akkina, R.6
Rossi, J.J.7
-
88
-
-
33645095226
-
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
-
Ng E.W., Shima D.T., Calias P., Cunningham E.T., Guyer D.R., Adamis A.P. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 2006, 5:123-132.
-
(2006)
Nat. Rev. Drug Discov.
, vol.5
, pp. 123-132
-
-
Ng, E.W.1
Shima, D.T.2
Calias, P.3
Cunningham, E.T.4
Guyer, D.R.5
Adamis, A.P.6
-
89
-
-
36749080289
-
Ranibizumab for the treatment of neovascular age-related macular degeneration: a review
-
Kourlas H., Abrams P. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review. Clin. Ther. 2007, 29:1850-1861.
-
(2007)
Clin. Ther.
, vol.29
, pp. 1850-1861
-
-
Kourlas, H.1
Abrams, P.2
-
90
-
-
0028609357
-
Isozyme-specific inhibition of protein kinase C by RNA aptamers
-
Conrad R., Keranen L.M., Ellington A.D., Newton A.C. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 1994, 269:32051-32054.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 32051-32054
-
-
Conrad, R.1
Keranen, L.M.2
Ellington, A.D.3
Newton, A.C.4
-
91
-
-
0029165745
-
High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus
-
Schneider D.J., Feigon J., Hostomsky Z., Gold L. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 1995, 34:9599-9610.
-
(1995)
Biochemistry
, vol.34
, pp. 9599-9610
-
-
Schneider, D.J.1
Feigon, J.2
Hostomsky, Z.3
Gold, L.4
-
93
-
-
2942679083
-
The immunobiology of the TLR9 subfamily
-
Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol. 2004, 25:381-386.
-
(2004)
Trends Immunol.
, vol.25
, pp. 381-386
-
-
Wagner, H.1
-
94
-
-
17644399512
-
Pharmacokinetics and biodistribution of novel aptamer compositions
-
Healy J.M., Lewis S.D., Kurz M., Boomer R.M., Thompson K.M., Wilson C., McCauley T.G. Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm. Res. 2004, 21:2234-2246.
-
(2004)
Pharm. Res.
, vol.21
, pp. 2234-2246
-
-
Healy, J.M.1
Lewis, S.D.2
Kurz, M.3
Boomer, R.M.4
Thompson, K.M.5
Wilson, C.6
McCauley, T.G.7
-
95
-
-
34548563975
-
2'F-ANA
-
Peng C.G., Damha M.J. G-quadruplex induced stabilization by 2'-deoxy-2'-fluoro-d-arabinonucleic acids. Nucleic Acids Res. 2007, 35:4977-4988.
-
(2007)
Nucleic Acids Res.
, vol.35
, pp. 4977-4988
-
-
Peng, C.G.1
Damha, M.J.2
-
96
-
-
0026802348
-
2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase
-
Aurup H., Williams D.M., Eckstein F. 2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry 1992, 31:9636-9641.
-
(1992)
Biochemistry
, vol.31
, pp. 9636-9641
-
-
Aurup, H.1
Williams, D.M.2
Eckstein, F.3
-
97
-
-
0028136665
-
The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine
-
Latham J.A., Johnson R., Toole J.J. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. Nucleic Acids Res. 1994, 22:2817-2822.
-
(1994)
Nucleic Acids Res.
, vol.22
, pp. 2817-2822
-
-
Latham, J.A.1
Johnson, R.2
Toole, J.J.3
-
98
-
-
0033559119
-
RNAP
-
Padilla R., Sousa R. Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutantT7 RNA polymerase. Nucleic Acids Res. 1999, 27:1561-1563.
-
(1999)
Nucleic Acids Res.
, vol.27
, pp. 1561-1563
-
-
Padilla, R.1
Sousa, R.2
-
99
-
-
0029114788
-
Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor
-
Jellinek D., Green L.S., Bell C., Lynott C.K., Gill N., Vargeese C., Kirschenheuter G., McGee D.P., Abesinghe P., Pieken W.A., et al. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 1995, 34:11363-11372.
-
(1995)
Biochemistry
, vol.34
, pp. 11363-11372
-
-
Jellinek, D.1
Green, L.S.2
Bell, C.3
Lynott, C.K.4
Gill, N.5
Vargeese, C.6
Kirschenheuter, G.7
McGee, D.P.8
Abesinghe, P.9
Pieken, W.A.10
-
100
-
-
0141792980
-
Aminomodified nucleobases: functionalized nucleoside triphosphates applicable for SELEX
-
Schoetzau T., Langner J., Moyroud E., Roehl I., Vonhoff S., Klussmann S. Aminomodified nucleobases: functionalized nucleoside triphosphates applicable for SELEX. Bioconjug. Chem. 2003, 14:919-926.
-
(2003)
Bioconjug. Chem.
, vol.14
, pp. 919-926
-
-
Schoetzau, T.1
Langner, J.2
Moyroud, E.3
Roehl, I.4
Vonhoff, S.5
Klussmann, S.6
-
101
-
-
0030955409
-
Post-SELEX combinatorial optimization of aptamers
-
Eaton B.E., Gold L., Hicke B.J., Janjic N., Jucker F.M., Sebesta D.P., Tarasow T.M., Willis M.C., Zichi D.A. Post-SELEX combinatorial optimization of aptamers. Bioorg. Med. Chem. 1997, 5:1087-1096.
-
(1997)
Bioorg. Med. Chem.
, vol.5
, pp. 1087-1096
-
-
Eaton, B.E.1
Gold, L.2
Hicke, B.J.3
Janjic, N.4
Jucker, F.M.5
Sebesta, D.P.6
Tarasow, T.M.7
Willis, M.C.8
Zichi, D.A.9
-
102
-
-
77958154053
-
Locked nucleic acid aptamers
-
Barciszewski J., Medgaard M., Koch T., Kurreck J., Erdmann V.A. Locked nucleic acid aptamers. Methods Mol. Biol. 2009, 535:165-186.
-
(2009)
Methods Mol. Biol.
, vol.535
, pp. 165-186
-
-
Barciszewski, J.1
Medgaard, M.2
Koch, T.3
Kurreck, J.4
Erdmann, V.A.5
-
103
-
-
6344277190
-
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA
-
Vester B., Wengel J. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 2004, 43:13233-13241.
-
(2004)
Biochemistry
, vol.43
, pp. 13233-13241
-
-
Vester, B.1
Wengel, J.2
-
104
-
-
0242610799
-
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity
-
Santulli-Marotto S., Nair S.K., Rusconi C., Sullenger B., Gilboa E. Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Res. 2003, 63:7483-7489.
-
(2003)
Cancer Res.
, vol.63
, pp. 7483-7489
-
-
Santulli-Marotto, S.1
Nair, S.K.2
Rusconi, C.3
Sullenger, B.4
Gilboa, E.5
-
105
-
-
38149096315
-
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
-
McNamara J.O., Kolonias D., Pastor F., Mittler R.S., Chen L., Giangrande P.H., Sullenger B., Gilboa E. Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J. Clin. Invest. 2008, 118:376-386.
-
(2008)
J. Clin. Invest.
, vol.118
, pp. 376-386
-
-
McNamara, J.O.1
Kolonias, D.2
Pastor, F.3
Mittler, R.S.4
Chen, L.5
Giangrande, P.H.6
Sullenger, B.7
Gilboa, E.8
-
106
-
-
0033543548
-
Antiproliferative activity of G-rich oligonucleotides correlates with protein binding
-
Bates P.J., Kahlon J.B., Thomas S.D., Trent J.O., Miller D.M. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J. Biol. Chem. 1999, 274:26369-26377.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 26369-26377
-
-
Bates, P.J.1
Kahlon, J.B.2
Thomas, S.D.3
Trent, J.O.4
Miller, D.M.5
-
107
-
-
33748335746
-
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin
-
Girvan A.C., Teng Y., Casson L.K., Thomas S.D., Juliger S., Ball M.W., Klein J.B., Pierce W.M., Barve S.S., Bates P.J. AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol. Cancer Ther. 2006, 5:1790-1799.
-
(2006)
Mol. Cancer Ther.
, vol.5
, pp. 1790-1799
-
-
Girvan, A.C.1
Teng, Y.2
Casson, L.K.3
Thomas, S.D.4
Juliger, S.5
Ball, M.W.6
Klein, J.B.7
Pierce, W.M.8
Barve, S.S.9
Bates, P.J.10
-
108
-
-
0037133510
-
Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications
-
Dapic V., Bates P.J., Trent J.O., Rodger A., Thomas S.D., Miller D.M. Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry 2002, 41:3676-3685.
-
(2002)
Biochemistry
, vol.41
, pp. 3676-3685
-
-
Dapic, V.1
Bates, P.J.2
Trent, J.O.3
Rodger, A.4
Thomas, S.D.5
Miller, D.M.6
-
109
-
-
68249159427
-
Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles
-
Tong G.J., Hsiao S.C., Carrico Z.M., Francis M.B. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J. Am. Chem. Soc. 2009, 131:11174-11178.
-
(2009)
J. Am. Chem. Soc.
, vol.131
, pp. 11174-11178
-
-
Tong, G.J.1
Hsiao, S.C.2
Carrico, Z.M.3
Francis, M.B.4
-
110
-
-
33750503424
-
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
-
Cheng J., Teply B.A., Sherifi I., Sung J., Luther G., Gu F.X., Levy-Nissenbaum E., Radovic-Moreno A.F., Langer R., Farokhzad O.C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007, 28:869-876.
-
(2007)
Biomaterials
, vol.28
, pp. 869-876
-
-
Cheng, J.1
Teply, B.A.2
Sherifi, I.3
Sung, J.4
Luther, G.5
Gu, F.X.6
Levy-Nissenbaum, E.7
Radovic-Moreno, A.F.8
Langer, R.9
Farokhzad, O.C.10
-
111
-
-
70349898026
-
Reversible cell-specific drug delivery with aptamer-functionalized liposomes
-
Cao Z., Tong R., Mishra A., Xu W., Wong G.C., Cheng J., Lu Y. Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angew. Chem. Int. Ed. Engl. 2009, 48:6494-6498.
-
(2009)
Angew. Chem. Int. Ed. Engl.
, vol.48
, pp. 6494-6498
-
-
Cao, Z.1
Tong, R.2
Mishra, A.3
Xu, W.4
Wong, G.C.5
Cheng, J.6
Lu, Y.7
-
112
-
-
33645238918
-
Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates
-
Chu T.C., Shieh F., Lavery L.A., Levy M., Richards-Kortum R., Korgel B.A., Ellington A.D. Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates. Biosensors & Bioelectronics 2006, 21:1859-1866.
-
(2006)
Biosensors & Bioelectronics
, vol.21
, pp. 1859-1866
-
-
Chu, T.C.1
Shieh, F.2
Lavery, L.A.3
Levy, M.4
Richards-Kortum, R.5
Korgel, B.A.6
Ellington, A.D.7
|